DRVD:OTC-Driven Deliveries, Inc (USD)

COMMON STOCK | Pharmaceutical Retailers | OTC

Last Closing Price

USD 0.80

Change

0.00 (0.00)%

Market Cap

USD 0.06B

Volume

0.58M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Driven Deliveries, Inc. engages in providing delivery services of legal cannabis products to consumers in California. The company provides e-commerce solutions, online sales, and on-demand cannabis delivery services. Driven Deliveries, Inc. was founded in 2013 and is based in San Diego, California. As of December 29, 2020, Driven Deliveries, Inc. operates as a subsidiary of Stem Holdings, Inc.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-06-20 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ALBHF Alibaba Health Information Tec..

N/A

USD29.27B 542.50 70.16
RADLY Raia Drogasil S.A

N/A

USD8.89B 84.14 4.34
CLCGY Clicks Group Limited

N/A

USD4.83B 34.98 1.11
ZRSEF Zur Rose Group AG

N/A

USD4.09B N/A N/A
SDGCF Sundrug Co.,Ltd

N/A

USD3.81B 16.60 0.08
FFLWF Fire & Flower Holdings Corp

N/A

USD0.29B N/A 11.91
RXMD Progressive Care, Inc

N/A

USD0.03B N/A 17.28
HADV Health Advance Inc

N/A

USD0.01B N/A N/A
HEWA HealthWarehouse.com, Inc

N/A

USD8.78M 56.67 N/A
RLLVF Relevium Technologies Inc

N/A

USD2.07M N/A N/A

ETFs Containing DRVD

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Pharmaceutical Retailers)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 100.00% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 100.00% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 33.33% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.33% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 660.14% 83% B 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 660.14% 83% B 95% A
Risk Return Profile  
Volatility (Standard Deviation) 1,447.73% 22% F 7% F
Risk Adjusted Return 45.60% 78% C+ 79% C+
Market Capitalization 0.06B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Pharmaceutical Retailers)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 19.85 N/A N/A N/A N/A
Price / Cash Flow Ratio -16.99 N/A N/A N/A N/A
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -1,114.10% N/A N/A N/A N/A
Return on Invested Capital -856.21% N/A N/A N/A N/A
Return on Assets -92.72% N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 6.66 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.